Ecnoglutide Reduces HbA1c and Body Weight in Type 2 Diabetes: Meta-Analysis
New diabetes drug cuts sugar and weight in adults with Type 2 Diabetes
A meta-analysis of 1643 adults with type 2 diabetes found that ecnoglutide significantly reduced HbA1c (MD -0.44, 95% CI -0.55 to -0.33) and…
A large review shows ecnoglutide lowers blood sugar and body weight in adults with Type 2 Diabetes. It also has an acceptable safety profile…
Fasting plasma glucose shows higher diagnostic accuracy than HbA1c for undiagnosed diabetes in adults
Fasting glucose outperforms HbA1c for Type 2 Diabetes diagnosis in adults
This systematic review and meta-analysis evaluated diagnostic performance in 276,203 adults without previously diagnosed diabetes.
A massive analysis of over 276,000 adults suggests fasting glucose is a more reliable diagnostic marker than HbA1c for Type 2 Diabetes.
Systematic review and meta-analysis links Mediterranean diet to improved cardiometabolic markers
Mediterranean-style eating lowers key blood sugar and heart risk markers in adults at risk
This systematic review and meta-analysis of 1337 adults at increased risk for type 2 diabetes and cardiovascular disease found that Mediterr…
A large review of studies shows Mediterranean-style eating lowers blood sugar and cholesterol markers in adults at risk for diabetes and hea…
Personalized diabetes texting with peer support improved glycemic control and remission rates in type 2 diabetes patients
Text Messages and Peer Support Can Help Reverse Type 2 Diabetes
This randomized controlled trial evaluated personalized diabetes texting combined with peer support education (DB-TEXT+ PSE) against standar…
Simple daily texts and group chats with others managing diabetes helped more people lower blood sugar and even reverse the condition compare…
Tirzepatide improves standard and intensive therapeutic target attainment versus semaglutide in adults with type 2 diabetes
New drug helps more patients hit four key health goals at once
This post hoc analysis of a randomised phase 3 study included 1879 adults with type 2 diabetes followed for 40 weeks.
A new diabetes medicine helps more people hit their blood sugar, weight, and blood pressure goals at the same time
A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes
Small diet changes might boost steps for a short time in diabetes care
This cluster-randomised controlled trial enrolled 204 adults aged 18-59 years with type 2 diabetes across 12 primary healthcare centres in B…
A simple diet plan helped people with diabetes walk more for three months but the extra steps did not stick in the long run
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
Oral sodium butyrate helps overweight adults without diabetes lose weight
This 12-week proof-of-concept RCT in 46 overweight adults (23 with type 2 diabetes) found that oral sodium butyrate 1875 mg/day led to great…
A new trial shows oral sodium butyrate helps adults without diabetes lose more weight than a placebo over three months.
Meta-analysis finds GLP-1RA plus SGLT2i reduces UACR in type 2 diabetes with kidney disease
Combining two diabetes drugs protects kidneys better than using just one alone
This systematic review and meta-analysis of 1974 adults with type 2 diabetes and diabetic kidney disease found that combination therapy with…
Combining two common diabetes drugs offers better kidney protection than taking just one alone for people with type 2 diabetes
Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
A new app plus support for diabetes care in Malaysia showed no benefit yet
This feasibility randomized controlled trial enrolled 60 women with gestational diabetes mellitus in Malaysia.
A trial in Malaysia found that a mobile app and group sessions did not improve health outcomes for women with gestational diabetes compared …
Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months
Essential Phospholipids Reduce Liver Fat In Six Months
This randomised, placebo-controlled phase 4 trial enrolled 193 patients with metabolic dysfunction-associated steatotic liver disease and ty…
Essential phospholipids may lower liver fat and improve energy levels for people with fatty liver disease and diabetes within just six month…
Systematic review and meta-analysis links Type 2 Diabetes to higher fracture risk across multiple anatomical sites
Type 2 Diabetes Linked To Higher Fracture Risk Across All Body Sites
This systematic review and meta-analysis evaluated fracture risk in 13,074,868 individuals with and without Type 2 Diabetes.
A massive analysis of over 13 million people found that having Type 2 Diabetes is associated with a significantly higher risk of breaking bo…
Systematic review and meta-analysis of hypoglycaemia risk prediction models in type 2 diabetes
Diabetes risk models predict hypoglycemia with moderate accuracy
This systematic review and meta-analysis of 25 studies (45 models) assessed hypoglycaemia risk prediction models in type 2 diabetes.
Models that predict dangerous blood sugar drops in type 2 diabetes are only moderately accurate, and most studies have serious flaws.